CNBX Pharmaceuticals Inc. (CNBX)
CNBX Stock Price Chart
Explore CNBX Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze CNBX price movements and trends.
CNBX Company Profile
Discover essential business fundamentals and corporate details for CNBX Pharmaceuticals Inc. (CNBX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Sept 2007
Employees
1.00
Website
https://www.cnbxpharma.comCEO
Eyal Barad
Description
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.
CNBX Financial Timeline
Browse a chronological timeline of CNBX Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 12 Jan 2026
Earnings released on 14 Jul 2025
EPS came in at -$0.00 .
Earnings released on 14 Apr 2025
EPS came in at -$0.00 .
Earnings released on 10 Jan 2025
EPS came in at -$0.00 .
Earnings released on 27 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached -$17.57K .
Earnings released on 15 Jul 2024
EPS came in at -$0.00 , while revenue for the quarter reached $17.57K .
Earnings released on 16 Apr 2024
EPS came in at -$0.01 , while revenue for the quarter reached $40.64K .
Earnings released on 12 Jan 2024
EPS came in at -$0.01 , while revenue for the quarter reached $89.44K .
Earnings released on 29 Nov 2023
EPS came in at -$0.03 , while revenue for the quarter reached $100.00K .
Earnings released on 14 Jul 2023
EPS came in at -$0.02 , while revenue for the quarter reached $310.17K .
Earnings released on 14 Apr 2023
EPS came in at -$1.34 .
Earnings released on 13 Jan 2023
EPS came in at -$0.28 .
Earnings released on 30 Nov 2022
EPS came in at -$0.39 , while revenue for the quarter reached $29.96K .
Earnings released on 14 Jul 2022
EPS came in at -$0.55 .
Stock split effective on 12 May 2022
Shares were split 1 : 120 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Apr 2022
EPS came in at -$1.42 .
Earnings released on 13 Jan 2022
EPS came in at -$1.21 .
Earnings released on 29 Nov 2021
EPS came in at -$0.56 .
Earnings released on 14 Jul 2021
EPS came in at -$1.17 .
Earnings released on 14 Apr 2021
EPS came in at -$0.47 .
Earnings released on 14 Jan 2021
EPS came in at -$0.58 .
Earnings released on 4 Nov 2020
EPS came in at -$0.65 , while revenue for the quarter reached $2.21K .
CNBX Stock Performance
Access detailed CNBX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.